Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,458 | -4,809 | 52,979 | 55,093 | -10,912 |
| Depreciation Amortization | 101 | 59 | 477 | 1,714 | 1,626 |
| Accounts receivable | 1,121 | 1,432 | -4,612 | -5,196 | -4,072 |
| Accounts payable and accrued liabilities | -987 | -726 | 4,090 | 1,215 | 2,167 |
| Other Working Capital | 2,710 | 2,714 | 4,728 | 443 | 1,062 |
| Other Operating Activity | -505 | 1,453 | -66,630 | -62,067 | 3,695 |
| Operating Cash Flow | $-1,018 | $123 | $-8,968 | $-8,798 | $-6,434 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -14 | -4 | -4 | -4 |
| Investing Cash Flow | $-14 | $-14 | $-4 | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 397 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 5,640 | 5,262 | 2,138 |
| Debt Repayment | N/A | N/A | -1,154 | -1,000 | N/A |
| Common Stock Issued | N/A | N/A | 290 | 174 | 160 |
| Other Financing Activity | 747 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,144 | $N/A | $4,776 | $4,436 | $2,298 |
| Beginning Cash Position | 580 | 580 | 4,776 | 4,776 | 4,776 |
| End Cash Position | 692 | 689 | 580 | 410 | 636 |
| Net Cash Flow | $112 | $109 | $-4,196 | $-4,366 | $-4,140 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,018 | 123 | -8,968 | -8,798 | -6,434 |
| Capital Expenditure | -14 | -14 | -4 | -4 | -4 |
| Free Cash Flow | -1,032 | 109 | -8,972 | -8,802 | -6,438 |